NSEUpdatesResults4 Aug 2026
Wonderla Holidays Limited
Updates
Wonderla Holidays Limited has informed the Exchange regarding 'Allotment of shares' and has approved unaudited Financial Results for the quarter ended 30th June, 2026, allotted 15,105 shares to employees, and granted 8,980 stock options to 2 employees.
BSEBoard MeetingResults4 Aug 2026
Prince Pipes and Fittings Ltd
Outcome of Board Meeting of the Company held on August 04, 2026
Prince Pipes and Fittings Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, along with a limited review report from its statutory auditors. The company has also announced the date of its 39th Annual General Meeting and authorized its KMPs to determine materiality of events and make disclosures to stock exchanges.
BSECompany UpdateResults4 Aug 2026
Dr. Agarwals Health Care Ltd
Presentation on the Unaudited Financial Results (Consolidated & Standalone) of the Company for the quarter ended June 30, 2026, is attached.
Dr. Agarwals Health Care Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with a presentation available on its website. The company has provided a disclaimer stating that the presentation is for general information purposes only and does not constitute an offer or invitation to purchase or sell securities.
BSEResultResults4 Aug 2026
Summit Securities Ltd
Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2026.
Summit Securities Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with the Board of Directors approving the results along with the Limited Review Reports of Statutory Auditors.
NSEMonthly Business UpdatesResults4 Aug 2026
Mahamaya Steel Industries Limited
Monthly Business Updates
Mahamaya Steel Industries Limited has informed the Exchange regarding Monthly Business Updates for the month of July 2026, announcing sales figures of 15589.190 MT.
NSERecord DateResults4 Aug 2026
Morepen Laboratories Limited
Record Date
Morepen Laboratories Limited has informed the Exchange that Record date for the purpose of Final Dividend is 19-Sep-2026. The company has also approved the financial results for the quarter ended 30th June 2026, and has announced the re-appointment of Mr. Sushil Suri as the Chairman & Managing Director of the company.
BSEAGM/EGMResults4 Aug 2026
Butterfly Gandhimathi Appliances Ltd
39th AGM of the Company
The 39th Annual General Meeting (AGM) of Butterfly Gandhimathi Appliances Limited was held through video conferencing (VC) and other audio-visual means (OAVM) on August 4, 2026. The meeting commenced at 11:00 AM (IST) and concluded at 11:50 AM (IST). The Board of Directors and Statutory Auditors were present at the meeting. The meeting was conducted in compliance with the circulars issued by the Ministry of Corporate Affairs and SEBI, and as per applicable provisions of the Companies Act, 2013 and the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
BSEOthersResults4 Aug 2026
Zenith Healthcare Ltd
Annual Report for Financial Year 2025-26.
Zenith Healthcare Ltd submitted its Annual Report for the financial year 2025-26 to the BSE, as per Regulation 34 of the SEBI (LODR) Regulations, 2015.
NSEAnalysts/Institutional Investor Meet/Con. Call UpdatesResults4 Aug 2026
GPT Healthcare Limited
Analysts/Institutional Investor Meet/Con. Call Updates
GPT Healthcare Limited informed the Exchange about the link of recording of a conference call held on August 4, 2026, to discuss the un-audited financial results for the 1st quarter ended on June 30, 2026.
NSEShareholders meetingResults4 Aug 2026
Butterfly Gandhimathi Appliances Limited
Shareholders meeting
Butterfly Gandhimathi Appliances Limited held its 39th Annual General Meeting through video conferencing on August 4, 2026, in compliance with relevant circulars and applicable provisions. The meeting considered the adoption of audited financial statements, appointment of a director, and ratification of remuneration payable to cost auditors.
BSECompany Update▲ PositiveResults4 Aug 2026
Repro India Ltd
Anaylyst Presentation for teh Quarter ended June 30, 2026
Repro India Ltd reported a 20% YoY growth in consolidated Q1 FY27 revenue, reaching Rs 141 cr, the highest quarterly revenue in its history. The company's digital biz vertical grew by 11% YoY, with the platform vertical growing by 24% YoY to Rs 74 cr, reaching an annualized run-rate of Rs 300 cr. The company has reported an exceptional gain of Rs 167 cr on account of income received from Mahape land sale.
BSEResultResults4 Aug 2026
Alembic Pharmaceuticals Ltd
Please find attached Unaudited Financial Results for the Quarter ended 30th June, 2026.
Alembic Pharmaceuticals Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with a net profit of Rs. 173.07 crores and earnings per share of Rs. 8.80.
BSEBoard Meeting▲ PositiveResults4 Aug 2026
Graphite India Ltd
Unaudited financial results for the quarter ended 30/06/2026
Graphite India Ltd has announced unaudited financial results for the quarter ended 30th June, 2026. The company reported a profit of ₹157 crore, with earnings per share (EPS) at ₹8.02. Revenue from operations was ₹765 crore, and total expenses were ₹674 crore. The company's segment revenue was ₹765 crore, with Graphite and Carbon segment contributing ₹651 crore. The company's total assets were ₹7,228 crore, and total liabilities were ₹1,437 crore.
NSEOutcome of Board Meeting▲ PositiveResults4 Aug 2026
Alembic Pharmaceuticals Limited
Outcome of Board Meeting
Alembic Pharmaceuticals Limited has submitted its financial results for the quarter ended June 30, 2026, with the Board of Directors approving the consolidated and standalone unaudited financial results along with the Limited Review Report issued by the Statutory Auditors.
BSECompany Update▲ PositiveResults4 Aug 2026
Emami Ltd-$
Press Release & Investor Presentation
Emami Ltd reported a 15% growth in consolidated revenues to ₹1,039 crore for the quarter ended June 2026, driven by a 20% growth in domestic business. EBITDA grew 6% to ₹226 crore despite higher input costs. The company made strategic investments in Axiom Ayurveda and IncNut, and remains optimistic about its growth prospects.
BSEBoard MeetingResults4 Aug 2026
Wonderla Holidays Ltd
Financial Results
Wonderla Holidays Ltd has announced its unaudited financial results for the quarter ended 30th June 2026, with revenue from operations at Rs. 24,262.84 lakhs and profit before tax at Rs. 9,346.54 lakhs. The company has also allotted 15,105 shares to employees under the Employee Stock Option Scheme 2016 and granted 8,980 stock options to 2 employees.
NSEOutcome of Board Meeting▲ PositiveResults4 Aug 2026
Wonderla Holidays Limited
Outcome of Board Meeting
Wonderla Holidays Limited has submitted its financial results for the quarter ended June 30, 2026, with a profit before tax of Rs. 9,346.54 lakhs and a total revenue of Rs. 25,210.21 lakhs. The company has also allotted 15,105 shares to employees and granted 8,980 stock options to two employees.
BSECompany UpdateResults4 Aug 2026
GEE Ltd
Q1 FY 27 Post Earnings Conference Call on 07th August, 2026 at 3:00 P.M. Link for registration is as follows: - https://events.kaptify.in/GEE-Q1-FY27-Concall
GEE Ltd has scheduled a Q1 FY27 post-earnings conference call on August 7, 2026, at 3:00 P.M. to discuss un-audited financial results for the quarter ended June 30, 2026.
BSECompany UpdateResults4 Aug 2026
GPT Healthcare Ltd
Please find enclosed herewith Audio recording of conference call for discussion on Un-Audited Financial Results for the 1st quarter ended on June 30, 2026 held today i.e August 4, 2026.
GPT Healthcare Ltd has released an audio recording of a conference call discussing its un-audited financial results for the 1st quarter ended June 30, 2026. The meeting was held on August 4, 2026, and no unpublished price-sensitive information was shared.
NSEInvestor Presentation▲ PositiveResults4 Aug 2026
Repro India Limited
Investor Presentation
Repro India Limited has informed the Exchange about Investor Presentation, showcasing Q1 FY27 performance highlights, including 20% YoY revenue growth, stable gross margins, and exceptional gain from Mahape land sale.